Proposed Data Collection Submitted for Public Comment and Recommendations, 40055-40057 [2021-15796]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
consistent with the standard meeting
process.
CMS will make all meeting materials
and related documents available at:
https://www.cms.gov/Medicare/Coding/
ICD10/C-and-M-Meeting-Materials. Any
inquiries related to the procedure code
topics scheduled for the September 14,
2021 ICD–10 Coordination and
Maintenance Committee meeting that
are under consideration for April 1,
2022 or October 1, 2022 implementation
should be sent to the CMS mailbox at:
ICDProcedureCodeRequest@
cms.hhs.gov.
ICD–10–CM Topics
1. Apnea of Newborn and Related Issues
2. Atrial Septal Defect
3. Craniosynostosis
4. Dementia
5. Encounter for follow-up examination
after completed treatment for
malignant neoplasm
6. Endometriosis
7. Intracranial Injury with Unknown
LOC
8. Long-term (current) drug therapy
9. Primary Blast Injury
10. Problems Related to Upbringing
11. Short Stature Due to Endocrine
Disorder
12. Addenda
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–15801 Filed 7–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jbell on DSKJLSW7X2PROD with NOTICES
[60Day–21–1046; Docket No. CDC–2021–
0074]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
VerDate Sep<11>2014
17:10 Jul 23, 2021
Jkt 253001
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP) Monitoring Activities.
Proposed study is designed to collect
information about implementation,
including delivery of screening and
follow-up clinical services, and
outcomes of the NBCCEDP.
DATES: CDC must receive written
comments on or before September 24,
2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0074 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
SUMMARY:
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
40055
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)
Monitoring Activities—(OMB Control
No. 0920–1046, Exp. 11/30/2021)—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a Revision of the
information collection with the OMB
Control Number 0920–1046, titled
‘‘National Breast and Cervical Cancer
Early Detection Program (NBCCEDP)
Monitoring Activities.’’ In the previous
OMB approval period, information
collection consisted of an annual
NBCCEDP survey and clinic-level data
collection. In the next OMB approval
period, information collection will
consist of a revised NBCCEDP survey,
revised clinic-level data collection, new
quarterly program update, new service
delivery projection worksheet, and the
addition of previously approved
minimum data elements (MDEs; OMB
Control No. 0920–0571, Exp. 11/30/
2021) to increase efficiency. The
number of respondents will remain the
same and the total estimated annualized
burden will increase from 683 to 1,216.
Breast and cervical cancers are
prevalent among U.S. women. In 2017,
the U.S. experienced 250,520 new cases
and 42,000 deaths as a result of breast
E:\FR\FM\26JYN1.SGM
26JYN1
40056
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
cancer, as well as 12,831 new cases and
4,207 deaths as a result of cervical
cancer. Evidence shows that deaths
from both breast and cervical cancers
can be avoided by increasing screening
services—mammography and PAP
tests—among women. However,
screening is typically underutilized
among women who are under- or
uninsured, have no regular source of
healthcare, or who recently immigrated
to the U.S. As a longstanding priority
within chronic disease prevention, CDC
focuses on increasing access to these
cancer screenings, particularly among
women who may be at increased risk.
To improve access to cancer
screening, Congress passed the Breast
and Cervical Cancer Mortality
Prevention Act of 1990 (Pub. L. 106–
354), which directed CDC to create the
National Breast and Cervical Cancer
Early Detection Program (NBCCEDP).
The NBCCEDP currently provides
funding to 70 awardees under ‘‘Cancer
Prevention and Control Programs for
State, Territorial, and Tribal
Organizations (DP17–1701).’’ NBCCEDP
awardees include states or their bona
fide agents; U.S. territories; and tribes or
tribal organizations. The purpose of
NBCCEDP is to increase breast and
cervical cancer screening rates among
women residing within defined
geographical locations (as determined
by the funded program) who are at or
below 250% of the federal poverty level;
aged 40–64 years for breast cancer
services, and aged 21–64 years for
cervical cancer services; and under- or
uninsured.
response options to improve data
quality. Third, quarterly program
updates will be submitted to CDC four
times per year to monitor award
spending, service delivery, staff
vacancies, program challenges and
successes, and TA needs. This is a new
information collection. Fourth, the
service delivery projection worksheet
will be submitted to CDC annually to
provide an estimate of the number of
women served for breast and cervical
cancer. Fifth, the minimum data
elements (MDEs) will be submitted to
CDC twice per year to monitor patient
demographics; breast and cervical
cancer screening, diagnosis, and
treatment; timeliness of services; and
patient navigation. This information
collection was previously approved
(OMB No. 0920–0571, exp. 03/30/2022)
and incorporated into this approval
package for increased efficiency for
NBCCEDP information collection
efforts.
The proposed information collections
will allow CDC to gauge progress in
meeting NBCCEDP program goals and
monitor implementation activities,
evaluate outcomes, and identify
awardee TA needs. In addition, findings
will inform program improvement and
help identify successful activities that
need to be maintained, replicated, or
expanded.
OMB approval is requested for three
years. CDC requests approval for an
estimated 1,216 annual burden hours.
Participation is required for NBCCEDP
awardees. There are no costs to
respondents other than their time.
In 2022, CDC will issue a new Notice
of Funding Opportunity (DP22–2202) to
continue this mission. Consistent with
programmatic changes, the information
collection plan has also been redesigned
to update existing, and add new data
collection instruments, and to integrate
the previously approved MDEs into this
single approval package to increase
efficiency of information collection for
the NBCCEDP. This revised information
collection will allow CDC to provide
routine monitoring feedback to
awardees based on their data
submissions, tailor technical assistance
(TA) as needed, support program
planning, and assess program outcomes.
CDC proposes five forms of
information collection. First, the
NBCCEDP survey will be submitted to
CDC annually and collects information
to monitor awardees’ TA needs, external
funding sources, partnerships, EBI
implementation, and COVID–19 impact.
Minor revisions to survey questions and
formatting reflect the program under
DP22–2202. Second, clinic-level data
will be submitted to CDC at baseline
and annually for all partnering health
system clinic sites—an estimated six
clinics per awardee for breast cancer
data and six clinics per awardee for
cervical cancer data. Clinic-level data
allow CDC to assess health system,
clinic, and patient population
characteristics; monitoring and quality
improvement activities; EBI
implementation; and baseline or annual
screening rates. Minor revisions were
made to variable wording, formatting
(e.g., split or combined variables), and
ESTIMATED ANNUALIZED BURDEN HOURS
jbell on DSKJLSW7X2PROD with NOTICES
Average
burden per
response
(in hours)
Total
burden
(in hours)
Form name
NBCCEDP Awardees ............
Annual NBCCEDP Survey ...........................
NBCCEDP Clinic-level Information Collection Instrument—Breast.
NBCCEDP Clinic-level Information Collection Instrument—Cervical.
Quarterly Program Update ...........................
Service Delivery Projection Worksheet ........
MDEs ............................................................
70
70
1
6
45/60
45/60
53
315
70
6
45/60
315
70
70
70
4
1
2
32/60
29/60
150/60
149
34
350
.......................................................................
........................
........................
........................
1,216
Total ...............................
VerDate Sep<11>2014
17:10 Jul 23, 2021
Jkt 253001
PO 00000
Frm 00067
Number of
respondents
Number of
responses per
respondent
Type of
respondents
Fmt 4703
Sfmt 9990
E:\FR\FM\26JYN1.SGM
26JYN1
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–15796 Filed 7–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0017; Docket No. CDC–2021–
0073]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Application for Training, which
supports the management and
evaluation of online training and
professional development opportunities
for public health and health care
professionals.
SUMMARY:
CDC must receive written
comments on or before September 24,
2021.
DATES:
You may submit comments,
identified by Docket No. CDC–2021–
0073 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
jbell on DSKJLSW7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:10 Jul 23, 2021
Jkt 253001
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Application for Training (OMB
Control No. 0920–0017, Exp. 04/30/
2022)—Revision—Center for
Surveillance, Epidemiology, and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
This Information Collection Request
(ICR) is for the Revision of a currently
approved ICR (OMB Control No. 0920–
0017, Expiration 4/30/2022. Approval is
requested for three years. The mission of
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
40057
CDC’s Division of Scientific Education
and Professional Development (DSEPD)
is to support the development of a
competent, sustainable, and empowered
public health workforce. Professionals
in public health, epidemiology,
medicine, economics, information
science, veterinary medicine, nursing,
public policy, and other related
professions seek professional
development opportunities (both
accredited and nonaccredited) through
two CDC learning management systems.
These two learning management
systems are Training and Continuing
Education Online (TCEO) (for
accredited courses) and CDC TRAIN (for
nonaccredited courses developed by
CDC programs, grantees, and other
funded partners). Access to quality and
accredited learning programs and
products through these two systems
allow for the public health workforce to
broaden their knowledge and skills to
improve the science and practice of
public health for domestic and
international impact.
The overarching purpose of the ICR is
to continually improve CDC training
activities, and maintain CDC
compliance with mandatory
accreditation organization standards by
efficiently collecting information
through CDC’s Training and Continuing
Education Online (TCEO) and CDC
TRAIN systems, while navigating a
future merger that moves to using a
single system (CDC TRAIN).
This Revision requests to extend
current approval of the TCEO forms,
with one minor change, namely to add
two new response options for one
question on the TCEO New Participant
Registration. This Revision also requests
to add CDC TRAIN as a data collection
system and add two CDC TRAIN
standard training evaluation tools (one
for use immediately after the course is
taken, and one 3–6 months after the
course is taken) that will be employed
on the learning management system.
This proposed change will provide CDC
with an efficient, effective, and secure
electronic mechanism for collecting,
processing, and monitoring trainingrelated information.
CDC will use information collected in
both systems to evaluate and improve
courses based on learner feedback. At
this time, TCEO is also used to generate
certificates of attendance and verify
training completion, review and
approve proposals for educational
activities to receive continuing
education accreditation, and ensure
compliance with mandatory
accreditation standards.
All data will be collected online,
using secure electronic web-based
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40055-40057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15796]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-1046; Docket No. CDC-2021-0074]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled National Breast and Cervical
Cancer Early Detection Program (NBCCEDP) Monitoring Activities.
Proposed study is designed to collect information about implementation,
including delivery of screening and follow-up clinical services, and
outcomes of the NBCCEDP.
DATES: CDC must receive written comments on or before September 24,
2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0074 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) Monitoring Activities--(OMB Control No. 0920-1046, Exp. 11/
30/2021)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a Revision of the information collection with the
OMB Control Number 0920-1046, titled ``National Breast and Cervical
Cancer Early Detection Program (NBCCEDP) Monitoring Activities.'' In
the previous OMB approval period, information collection consisted of
an annual NBCCEDP survey and clinic-level data collection. In the next
OMB approval period, information collection will consist of a revised
NBCCEDP survey, revised clinic-level data collection, new quarterly
program update, new service delivery projection worksheet, and the
addition of previously approved minimum data elements (MDEs; OMB
Control No. 0920-0571, Exp. 11/30/2021) to increase efficiency. The
number of respondents will remain the same and the total estimated
annualized burden will increase from 683 to 1,216.
Breast and cervical cancers are prevalent among U.S. women. In
2017, the U.S. experienced 250,520 new cases and 42,000 deaths as a
result of breast
[[Page 40056]]
cancer, as well as 12,831 new cases and 4,207 deaths as a result of
cervical cancer. Evidence shows that deaths from both breast and
cervical cancers can be avoided by increasing screening services--
mammography and PAP tests--among women. However, screening is typically
underutilized among women who are under- or uninsured, have no regular
source of healthcare, or who recently immigrated to the U.S. As a
longstanding priority within chronic disease prevention, CDC focuses on
increasing access to these cancer screenings, particularly among women
who may be at increased risk.
To improve access to cancer screening, Congress passed the Breast
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 106-354),
which directed CDC to create the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP). The NBCCEDP currently provides
funding to 70 awardees under ``Cancer Prevention and Control Programs
for State, Territorial, and Tribal Organizations (DP17-1701).'' NBCCEDP
awardees include states or their bona fide agents; U.S. territories;
and tribes or tribal organizations. The purpose of NBCCEDP is to
increase breast and cervical cancer screening rates among women
residing within defined geographical locations (as determined by the
funded program) who are at or below 250% of the federal poverty level;
aged 40-64 years for breast cancer services, and aged 21-64 years for
cervical cancer services; and under- or uninsured.
In 2022, CDC will issue a new Notice of Funding Opportunity (DP22-
2202) to continue this mission. Consistent with programmatic changes,
the information collection plan has also been redesigned to update
existing, and add new data collection instruments, and to integrate the
previously approved MDEs into this single approval package to increase
efficiency of information collection for the NBCCEDP. This revised
information collection will allow CDC to provide routine monitoring
feedback to awardees based on their data submissions, tailor technical
assistance (TA) as needed, support program planning, and assess program
outcomes.
CDC proposes five forms of information collection. First, the
NBCCEDP survey will be submitted to CDC annually and collects
information to monitor awardees' TA needs, external funding sources,
partnerships, EBI implementation, and COVID-19 impact. Minor revisions
to survey questions and formatting reflect the program under DP22-2202.
Second, clinic-level data will be submitted to CDC at baseline and
annually for all partnering health system clinic sites--an estimated
six clinics per awardee for breast cancer data and six clinics per
awardee for cervical cancer data. Clinic-level data allow CDC to assess
health system, clinic, and patient population characteristics;
monitoring and quality improvement activities; EBI implementation; and
baseline or annual screening rates. Minor revisions were made to
variable wording, formatting (e.g., split or combined variables), and
response options to improve data quality. Third, quarterly program
updates will be submitted to CDC four times per year to monitor award
spending, service delivery, staff vacancies, program challenges and
successes, and TA needs. This is a new information collection. Fourth,
the service delivery projection worksheet will be submitted to CDC
annually to provide an estimate of the number of women served for
breast and cervical cancer. Fifth, the minimum data elements (MDEs)
will be submitted to CDC twice per year to monitor patient
demographics; breast and cervical cancer screening, diagnosis, and
treatment; timeliness of services; and patient navigation. This
information collection was previously approved (OMB No. 0920-0571, exp.
03/30/2022) and incorporated into this approval package for increased
efficiency for NBCCEDP information collection efforts.
The proposed information collections will allow CDC to gauge
progress in meeting NBCCEDP program goals and monitor implementation
activities, evaluate outcomes, and identify awardee TA needs. In
addition, findings will inform program improvement and help identify
successful activities that need to be maintained, replicated, or
expanded.
OMB approval is requested for three years. CDC requests approval
for an estimated 1,216 annual burden hours. Participation is required
for NBCCEDP awardees. There are no costs to respondents other than
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees.............. Annual NBCCEDP 70 1 45/60 53
Survey.
NBCCEDP Clinic- 70 6 45/60 315
level
Information
Collection
Instrument--Bre
ast.
NBCCEDP Clinic- 70 6 45/60 315
level
Information
Collection
Instrument--Cer
vical.
Quarterly 70 4 32/60 149
Program Update.
Service Delivery 70 1 29/60 34
Projection
Worksheet.
MDEs............ 70 2 150/60 350
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,216
----------------------------------------------------------------------------------------------------------------
[[Page 40057]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-15796 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P
